Liquidity Events
Carlyle Group sells nearly 11% stake in pharma co. Viyash Scientific for Rs.1,259.4 Cr
Hyderabad-based, listed pharmaceutical company Viyash Scientific (formerly known as Sequent Scientific), saw its PE investor, Carlyle Group (via CA Hull Investments and CA Harbor Investments) sell a 10.88% stake via open market transactions on August 26. The sale fetched a total of INR 1,259.4-Cr.Founded in 1985, Viyash manufactures active pharmaceutical ingredients (APIs), advanced intermediates, and finished medicine formulations for human and animal health.
Between Jul 2015 and May 2020, SeQuent Scientific had attracted about $ 169 M from Ascent Capital, Convergent Finance, Carlyle.For FY26, SeQuent Scientific had reported about INR 1,382 Cr in Operating Income and about INR 76 Cr in PAT.
Want to receive such news items in your inbox? Click Here to sign up for a trial.
